Literature DB >> 8951961

Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions.

A Shekhar1, S R Keim, J R Simon, W J McBride.   

Abstract

Since impairing gamma-aminobutyric acidA (GABAA) receptor-mediated inhibition in the dorsomedial hypothalamus (DMH) of rats elicits a panic-like response, experiments were conducted to test if rats with GABA dysfunction in the DMH would be vulnerable to precipitation of a panic-like response after intravenous sodium lactate infusions. Rats were implanted with unilateral infusion cannula into the DMH which were connected with Alzet minipumps that chronically infused (3.5 nmol/microliter /h) either a-CSF (vehicle), dl-(racemic), l-(active) or d-(inactive) isomers of allylglycine (AG), an inhibitor of GABA synthesis. Another group of rats had l-allylglycine pumps implanted in the paraventricular nucleus of the hypothalamus (PVN) as anatomical controls. Animals were tested in the social interaction (SI) test and given sodium lactate infusions (10 ml/kg/15 min) before Alzet pump implantations and on days 4, 7, and 14 after pump placement. Rats were also tested in the elevated plus-maze on treatment day 4. Chronic impairment of GABA function in the DMH and not PVN resulted in rats being more anxious in the SI test on treatment days 4, 7, and 14 and in the elevated plus-maze on day 4 compared to a-CSF and d-AG infusions. Further, rats with GABA dysfunction in the DMH, and not PVN, exhibited significant increases in heart rate and blood pressure following IV sodium lactate infusions. There were significant decreases in DMH glutamic acid decarboxylase activity and GABA content in rats receiving 7 days of dl-AG or l-AG infusions. These results indicate that chronic reduction of GABA function in the DMH leads to the development of panic-like disorder in this animal model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951961     DOI: 10.1016/s0091-3057(96)00077-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  33 in total

1.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 2.  Organization of brain somatomotor-sympathetic circuits.

Authors:  Ilan A Kerman
Journal:  Exp Brain Res       Date:  2008-03-28       Impact factor: 1.972

3.  Dorsomedial hypothalamus mediates autonomic, neuroendocrine, and locomotor responses evoked from the medial preoptic area.

Authors:  Joseph L Hunt; Dmitry V Zaretsky; Sumit Sarkar; Joseph A Dimicco
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

Review 4.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 5.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

6.  A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects.

Authors:  Pascal Bonaventure; Sujin Yun; Philip L Johnson; Anantha Shekhar; Stephanie D Fitz; Brock T Shireman; Terry P Lebold; Diane Nepomuceno; Brian Lord; Michelle Wennerholm; Jonathan Shelton; Nicholas Carruthers; Timothy Lovenberg; Christine Dugovic
Journal:  J Pharmacol Exp Ther       Date:  2015-01-12       Impact factor: 4.030

7.  Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.

Authors:  Younglim Lee; Stephanie Fitz; Philip L Johnson; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

8.  Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.

Authors:  Philip L Johnson; Tammy J Sajdyk; Stephanie D Fitz; Mathew W Hale; Christopher A Lowry; Anders Hay-Schmidt; Anantha Shekhar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-21       Impact factor: 5.067

9.  Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats.

Authors:  Philip L Johnson; Stephanie D Fitz; Eric A Engleman; Kjell A Svensson; Jeffrey M Schkeryantz; Anantha Shekhar
Journal:  J Psychopharmacol       Date:  2012-08-21       Impact factor: 4.153

10.  A key role for orexin in panic anxiety.

Authors:  Philip L Johnson; William Truitt; Stephanie D Fitz; Pamela E Minick; Amy Dietrich; Sonal Sanghani; Lil Träskman-Bendz; Andrew W Goddard; Lena Brundin; Anantha Shekhar
Journal:  Nat Med       Date:  2009-12-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.